期刊文献+

Metabolic Control ofγδT Cell Function

原文传递
导出
摘要 Metabolic change is associated with cell activities,such as signal transduction,cell differentiation,and cell cycle.In the pathogenesis of autoimmune diseases,abnormal activation of T cells is often accompanied by changes in their metabolism.Conversely,the changes of metabolites can also regulate the proliferation,differentiation,and function of T cells.As a bridge between innate and adaptive immune responses,γδT cells have unique biological characteristics and functions.However,the immunometabolic mechanism ofγδT cells has been a novel field for research in recent years.In this review,we summarize the influence of metabolic pathways and nutrients onγδT cell function,and metabolic features ofγδT cell subsets,which may provide new insights in interventions targetingγδT cells in disease control.
出处 《Infectious Microbes & Diseases》 2021年第3期142-148,共7页 感染微生物与疾病(英文)
基金 supported by the grants from the National Natural Science Foundation of China(31830021 and 32030036 to ZY,31970830 to JH,32070121 to HY,31800722 to ZM) grant from the Ministry of Science and Technology of China(2020YFA0803500 to ZY),and grant from the Zhuhai Science and Technology Innovation Bureau(ZH22036302200063PWC to ZY).
  • 相关文献

参考文献2

二级参考文献34

  • 1Schattenberg.lM and Schuppan D. Nonalcoholic steatohepariris: the therapeutic challenge of a global epidemic. Curr Opin Lipidol 20 I I, 22: 479-488.
  • 2Paredes AH, Torres OM and Harrison SA. Nonalcoholic fatty liver disease. Clin Liver Dis 2012, 16: 397-419.
  • 3Kleiner DE and Brunt EM. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Sernin Liver Dis 2012, 32: 3-13.
  • 4Martel C, Esposti DO, Bouchet A, Brenner C and Lemoine A. Non-alcoholic stearohepatiris: new insights from OMICS studies. Curr Phann Biotechnol 2012, 13: 726- 735.
  • 5Braunersrcuther V, Viviani GL, Mach F and Montecucco F. Role of cyrokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol 2012, 18: 727- 735.
  • 6Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN and Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol2008, 103: 1372-1379.
  • 7Videla LA, Tapia G, Rodrigo R, Pettinelli P, Haim D, Santibanez C and Araya AV, et al. LiverNF-kappaB and AP-I DNA binding in obese patients. Obesity (Silver Spring) 2009, 17: 973 -979.
  • 8Li L, Chen L, Hu L, Liu Y, Sun HY, Tang J and Hou YJ, et al. Nuclear factor high-mobility group box I mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology 2011,54: 1620-1630.
  • 9Park HJ, Lee JY, Chung MY, Park YK, Bower AM, Koo SI and Giardina C, et al. Green tea extract suppresses NFkappaB activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis. J Nutr 2012, 142: 57-63.
  • 10Farrell GC, van Rooyen D, Gan Land Chitturi S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 2012,6: 149-171.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部